Aura Biosciences, Inc. (AURA) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$112.79M | -17.3% |
| 2024 | -$96.12M | -13.1% |
| 2023 | -$84.99M | -41.0% |
| 2022 | -$60.30M | -71.0% |
| 2021 | -$35.25M | -58.7% |
| 2020 | -$22.21M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$112.79M | -17.3% |
| 2024 | -$96.12M | -13.1% |
| 2023 | -$84.99M | -41.0% |
| 2022 | -$60.30M | -71.0% |
| 2021 | -$35.25M | -58.7% |
| 2020 | -$22.21M | — |